Co-founder of BlackRock Private Equity Partners (PEP), having served as Chairman of PEPs Investment Operating Committee. He leads the capital formation process while sharing the strategic management of the Company with Mr. Woodall.

Previously served as president of Johnson & Johnson's Interventional Systems, Inc. leading the team responsible for pioneering the transformational cardiovascular stent franchise. He served as the CEO of the Cardiovascular Research Foundation and as Chairman or board member of multiple medical devices and hospital systems as well as civic organizations.

While maintaining his full medical and academic responsibilities at the Temple University and Hospital systems, provides the ex-officio Chief Medical Officer role for the company. Dr. Bashir shares the product design responsibilities with Mr. Green and leads the pre-clinical testing, regulatory and clinical plans.

Leads the technical design implementation process. Nick brings extensive experience in the cardiovascular catheter field, including the Johnson & Johnson, Cordis franchise in the stent and related devices fields.

a cardiologist, leads the regulatory, clinical, and reimbursement activities. He previously served as the Chief Scientific Officer of J&J Interventional Systems, Inc. under Marvin Woodall, and subsequently as Vice President of Research and Development, Clinical Research, and Health Economics and Reimbursement, successively, at Johnson & Johnson’s Cordis franchise.